+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 129 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 3765945
Description Jump to:
The global blood testing market size is expected to reach USD 160.50 billion by 2030, expandingat a CAGR of 7.23% from 2023 to 2030. The growth of the market is attributable to various factors including the growing demand for the identification of infectious agents and increased healthcare spending by government and regulatory bodies. Furthermore, the rising prevalence of infectious diseases, such as diabetes, COVID-19, and cardiovascular diseases, is anticipated to drive market growth. For instance, according to the CDC in 2022, approximately 37.3 million people were diagnosed with diabetes in the United States, accounting for 11.3 % of the population.

This increasing prevalence of diabetes creates a significant demand for blood tests, thus contributing to the growth of the market. Furthermore, technological advancement in the products used for blood testing fuels the growth of the market. The availability of portable glucose meters that enable patients to perform routine checkups conveniently and anywhere has contributed to an expansion of the market. In addition, the monitoring of diabetes is crucial prior to any surgical intervention for patients with diabetes, which further drives the demand for these products. The introduction of new products is anticipated to fuel market growth over the projection period.

For instance, in May 2022, Labcorp introduced an at-home collection kit with Labcorp OnDemand, which allows individuals to measure their hemoglobin A1c (HbA1c) levels from a small blood sample to monitor their sugar levels. Key organizations, such as the American Red Cross, the New York Blood Center, America's Blood Centers, Armed Services Blood Program, AABB, and Blood Centers of America, play a crucial role in providing information on plasma collection and delivery. The rise in blood donations is expected to further drive the demand for testing products used in pre-transplant and post-transplant procedures, thereby boosting market growth.

Blood Testing Market Report Highlights

  • The glucose testing segment held the largest revenue share in 2022. The segment growth is supported by the increasing prevalence of both type I and type II diabetes, along with the growing number of cases related to hereditary diabetes
  • The market is expected to witness increased revenue generation in the at-home A1C testing segment due to higher adoption rates. It was the second-largest testing segment in 2022
  • Continuous advancements in technology have led to the development of innovative blood testing methods and devices. These advancements, such as point-of-care testing, wearable devices, and improved laboratory testing techniques, drive market growth.
  • The COVID-19 pandemic has significantly increased the demand for blood testing, including diagnostic tests for the virus, antibody testing, and monitoring of COVID-19 patients' health status
  • North America held the largest revenue share in 2022 and is expected to maintain its position throughout the forecast period; however, Asia Pacific is expected to grow at a faster rate from 2023 to 2030
  • Key players operating are focusing on product launches and geographical expansion to maintain their presence. For instance, in March 2023, Apple made notable progress in the development of non-invasive blood glucose monitoring technology, enabling individuals with diabetes and other conditions to measure their blood glucose levels without the need for skin pricks or traditional blood testing methods
  • In June 2022, Apollo Cancer Centers, in collaboration with Datar Cancer Genetics, introduced a blood test capable of detecting early-stage breast cancers in asymptomatic individuals

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of target disease
3.2.1.2. Growing demand for point-of-care tests
3.2.1.3. Implementation of favorable government initiatives & external funding for R&D activities
3.2.1.4. Introduction of CLIA waived tests
3.2.1.5. Rising demand for early disease detection
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulatory and reimbursement policies
3.2.2.2. Limitations associated with blood testing
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Test Type Business Analysis
4.1. Blood Testing Market: Test Type Movement Analysis
4.2. Glucose Testing
4.2.1. Glucose Testing Market, 2018 - 2030 (USD Million)
4.3. A1C Testing
4.3.1. A1C Testing Market, 2018 - 2030 (USD Million)
4.4. Direct LDL Testing
4.4.1. Direct LDL Testing Market, 2018 - 2030 (USD Million)
4.5. Lipid Panel Testing
4.5.1. Lipid Panel Testing Market, 2018 - 2030 (USD Million)
4.6. Prostate-specific Antigen Testing
4.6.1. Prostate-specific Antigen Testing Market, 2018 - 2030 (USD Million)
4.7. COVID-19 Testing
4.7.1. COVID-19 Testing Market, 2018 - 2030 (USD Million)
4.8. BUN Testing
4.8.1. BUN Testing Market, 2018 - 2030 (USD Million)
4.9. Vitamin D Testing
4.9.1. Vitamin D Testing Market, 2018 - 2030 (USD Million)
4.10. Thyroid-stimulating Hormone (TSH) Testing
4.10.1. Thyroid-stimulating Hormone (TSH) Testing Market, 2018 - 2030 (USD Million)
4.11. Serum Nicotine/Cotinine Testing
4.11.1. Serum Nicotine/Cotinine Testing Market, 2018 - 2030 (USD Million)
4.12. High Sensitivity CRP Testing
4.12.1. High Sensitivity CRP Testing Market, 2018 - 2030 (USD Million)
4.13. Testosterone Testing
4.13.1. Testosterone Testing Market, 2018 - 2030 (USD Million)
4.14. ALT Testing
4.14.1. ALT Testing Market, 2018 - 2030 (USD Million)
4.15. Cortisol Testing
4.15.1. Cortisol Testing Market, 2018 - 2030 (USD Million)
4.16. Creatinine Testing
4.16.1. Creatinine Testing Market, 2018 - 2030 (USD Million)
4.17. AST Testing
4.17.1. AST Testing Market, 2018 - 2030 (USD Million)
4.18. Other Blood Tests
4.18.1. Other Blood Tests Market, 2018 - 2030 (USD Million)
Chapter 5. Regional Business Analysis
5.1. Blood Testing Market Share By Region, 2022 & 2030
5.2. North America
5.2.1. SWOT Analysis
5.2.2. North America Blood Testing Market, 2018 - 2030 (USD Million)
5.2.3. U.S.
5.2.3.1. Key Country Dynamics
5.2.3.2. Target Disease Prevalence
5.2.3.3. Competitive Scenario
5.2.3.4. Regulatory Framework
5.2.3.5. U.S. Blood Testing Market, 2018 - 2030 (USD Million)
5.2.4. Canada
5.2.4.1. Key Country Dynamics
5.2.4.2. Target Disease Prevalence
5.2.4.3. Competitive Scenario
5.2.4.4. Regulatory Framework
5.2.4.5. Canada Blood Testing Market, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. SWOT Analysis
5.3.2. Europe Blood Testing Market, 2018 - 2030 (USD Million)
5.3.3. UK
5.3.3.1. Key Country Dynamics
5.3.3.2. Target Disease Prevalence
5.3.3.3. Competitive Scenario
5.3.3.4. Regulatory Framework
5.3.3.5. UK Blood Testing Market, 2018 - 2030 (USD Million)
5.3.4. Germany
5.3.4.1. Key Country Dynamics
5.3.4.2. Target Disease Prevalence
5.3.4.3. Competitive Scenario
5.3.4.4. Regulatory Framework
5.3.4.5. Germany Blood Testing Market, 2018 - 2030 (USD Million)
5.3.5. France
5.3.5.1. Key Country Dynamics
5.3.5.2. Target Disease Prevalence
5.3.5.3. Competitive Scenario
5.3.5.4. Regulatory Framework
5.3.5.5. France Blood Testing Market, 2018 - 2030 (USD Million)
5.3.6. Italy
5.3.6.1. Key Country Dynamics
5.3.6.2. Target Disease Prevalence
5.3.6.3. Competitive Scenario
5.3.6.4. Regulatory Framework
5.3.6.5. Italy Blood Testing Market, 2018 - 2030 (USD Million)
5.3.7. Spain
5.3.7.1. Key Country Dynamics
5.3.7.2. Target Disease Prevalence
5.3.7.3. Competitive Scenario
5.3.7.4. Regulatory Framework
5.3.7.5. Spain Blood Testing Market, 2018 - 2030 (USD Million)
5.3.8. Sweden
5.3.8.1. Key Country Dynamics
5.3.8.2. Target Disease Prevalence
5.3.8.3. Competitive Scenario
5.3.8.4. Regulatory Framework
5.3.8.5. Sweden Blood Testing Market, 2018 - 2030 (USD Million)
5.3.9. Norway
5.3.9.1. Key Country Dynamics
5.3.9.2. Target Disease Prevalence
5.3.9.3. Competitive Scenario
5.3.9.4. Regulatory Framework
5.3.9.5. Norway Blood Testing Market, 2018 - 2030 (USD Million)
5.3.10. Denmark
5.3.10.1. Key Country Dynamics
5.3.10.2. Target Disease Prevalence
5.3.10.3. Competitive Scenario
5.3.10.4. Regulatory Framework
5.3.10.5. Denmark Blood Testing Market, 2018 - 2030 (USD Million)
5.3.11. Russia
5.3.11.1. Key Country Dynamics
5.3.11.2. Target Disease Prevalence
5.3.11.3. Competitive Scenario
5.3.11.4. Regulatory Framework
5.3.11.5. Russia Blood Testing Market, 2018 - 2030 (USD Million)
5.3.12. Turkey
5.3.12.1. Key Country Dynamics
5.3.12.2. Target Disease Prevalence
5.3.12.3. Competitive Scenario
5.3.12.4. Regulatory Framework
5.3.12.5. Turkey Blood Testing Market, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. SWOT Analysis
5.4.2. Asia Pacific Blood Testing Market, 2018 - 2030 (USD Million)
5.4.3. Japan
5.4.3.1. Key Country Dynamics
5.4.3.2. Target Disease Prevalence
5.4.3.3. Competitive Scenario
5.4.3.4. Regulatory Framework
5.4.3.5. Japan Blood Testing Market, 2018 - 2030 (USD Million)
5.4.4. China
5.4.4.1. Key Country Dynamics
5.4.4.2. Target Disease Prevalence
5.4.4.3. Competitive Scenario
5.4.4.4. Regulatory Framework
5.4.4.5. China Blood Testing Market, 2018 - 2030 (USD Million)
5.4.5. India
5.4.5.1. Key Country Dynamics
5.4.5.2. Target Disease Prevalence
5.4.5.3. Competitive Scenario
5.4.5.4. Regulatory Framework
5.4.5.5. India Blood Testing Market, 2018 - 2030 (USD Million)
5.4.6. Australia
5.4.6.1. Key Country Dynamics
5.4.6.2. Target Disease Prevalence
5.4.6.3. Competitive Scenario
5.4.6.4. Regulatory Framework
5.4.6.5. Australia Blood Testing Market, 2018 - 2030 (USD Million)
5.4.7. Thailand
5.4.7.1. Key Country Dynamics
5.4.7.2. Target Disease Prevalence
5.4.7.3. Competitive Scenario
5.4.7.4. Regulatory Framework
5.4.7.5. Thailand Blood Testing Market, 2018 - 2030 (USD Million)
5.4.8. South Korea
5.4.8.1. Key Country Dynamics
5.4.8.2. Target Disease Prevalence
5.4.8.3. Competitive Scenario
5.4.8.4. Regulatory Framework
5.4.8.5. South Korea Blood Testing Market, 2018 - 2030 (USD Million)
5.4.9. Indonesia
5.4.9.1. Key Country Dynamics
5.4.9.2. Target Disease Prevalence
5.4.9.3. Competitive Scenario
5.4.9.4. Regulatory Framework
5.4.9.5. Indonesia Blood Testing Market, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. SWOT Analysis
5.5.2. Latin America Blood Testing Market, 2018 - 2030 (USD Million)
5.5.3. Brazil
5.5.3.1. Key Country Dynamics
5.5.3.2. Target Disease Prevalence
5.5.3.3. Competitive Scenario
5.5.3.4. Regulatory Framework
5.5.3.5. Brazil Blood Testing Market, 2018 - 2030 (USD Million)
5.5.4. Mexico
5.5.4.1. Key Country Dynamics
5.5.4.2. Target Disease Prevalence
5.5.4.3. Competitive Scenario
5.5.4.4. Regulatory Framework
5.5.4.5. Mexico Blood Testing Market, 2018 - 2030 (USD Million)
5.5.5. Argentina
5.5.5.1. Key Country Dynamics
5.5.5.2. Target Disease Prevalence
5.5.5.3. Competitive Scenario
5.5.5.4. Regulatory Framework
5.5.5.5. Argentina Blood Testing Market, 2018 - 2030 (USD Million)
5.6. MEA
5.6.1. SWOT Analysis
5.6.2. MEA Blood Testing Market, 2018 - 2030 (USD Million)
5.6.3. South Africa
5.6.3.1. Key Country Dynamics
5.6.3.2. Target Disease Prevalence
5.6.3.3. Competitive Scenario
5.6.3.4. Regulatory Framework
5.6.3.5. South Africa Blood Testing Market, 2018 - 2030 (USD Million)
5.6.4. Saudi Arabia
5.6.4.1. Key Country Dynamics
5.6.4.2. Target Disease Prevalence
5.6.4.3. Competitive Scenario
5.6.4.4. Regulatory Framework
5.6.4.5. Saudi Arabia Blood Testing Market, 2018 - 2030 (USD Million)
5.6.5. UAE
5.6.5.1. Key Country Dynamics
5.6.5.2. Target Disease Prevalence
5.6.5.3. Competitive Scenario
5.6.5.4. Regulatory Framework
5.6.5.5. UAE Blood Testing Market, 2018 - 2030 (USD Million)
5.6.6. Kuwait
5.6.6.1. Key Country Dynamics
5.6.6.2. Target Disease Prevalence
5.6.6.3. Competitive Scenario
5.6.6.4. Regulatory Framework
5.6.6.5. Kuwait Blood Testing Market, 2018 - 2030 (USD Million)
5.6.7. Nigeria
5.6.7.1. Key Country Dynamics
5.6.7.2. Target Disease Prevalence
5.6.7.3. Competitive Scenario
5.6.7.4. Regulatory Framework
5.6.7.5. Nigeria Blood Testing Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.3. Company Market Share Analysis, 2022
6.4. Company Profiles/Listing
6.4.1. F. Hoffmann-La Roche Ltd
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. Abbott
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Bio-Rad Laboratories, Inc.
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. bioMerieux SA
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. Quest Diagnostics
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. Biomerica, Inc
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Becton, Dickinson and Company
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Siemens Healthineers
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives
6.4.9. Danaher Corporation
6.4.9.1. Overview
6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiatives
6.4.10. Trinity Biotech Plc
6.4.10.1. Overview
6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Blood Testing Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 5 North America Blood Testing Market, By Country, 2018 - 2030 (USD Million)
Table 6 North America Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 7 U.S. America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 8 Canada America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 9 Europe America Blood Testing Market, by country, 2018 - 2030 (USD Million)
Table 10 Europe America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 11 UK America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 12 Germany America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 13 France America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 14 Italy America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 15 Spain America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 16 Sweden America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 17 Norway America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 18 Russia America Blood Testing Market, by Test Type, 2018 - 2030 (USD)
Table 19 Denmark America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 20 Turkey America Blood Testing Market, by Test Type, 2018 - 2030 (USD)
Table 21 Asia Pacific America Blood Testing Market, by country, 2018 - 2030 (USD Million)
Table 22 Asia Pacific America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 23 Japan America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 24 China America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 25 India America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 26 Australia America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 27 Thailand America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 28 South Korea America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 29 Indonesia America Blood Testing Market, by Test Type, 2018 - 2030 (USD)
Table 30 Latin America Blood Testing Market, by country, 2018 - 2030 (USD Million)
Table 31 Latin America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 32 Brazil America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 33 Mexico America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 34 Argentina America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 35 Middle East & Africa America Blood Testing Market, by country, 2018 - 2030 (USD Million)
Table 36 Middle East & Africa America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 37 South Africa America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 38 Saudi Arabia America Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 39 UAE Blood Testing Market, by Test Type, 2018 - 2030 (USD Million)
Table 40 UAE Blood Testing Market, by application, 2018 - 2030 (USD)
Table 41 Kuwait America Blood Testing Market, by application, 2018 - 2030 (USD)
Table 42 Nigeria Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Blood Testing Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Neglected tropical diseases diagnosis market: Test type outlook and key takeaways
Fig. 15 Neglected tropical diseases diagnosis market: Test type movement analysis & market share 2022 & 2030
Fig. 16 Global glucose testing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 17 Global A1C testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Global direct LDL testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Global lipid panel testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Global PSA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Global COVID-19 testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Global BUN testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Global Vitamin D testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Global TSH testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Global serum nicotine/cotinine testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Global CRP testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Global testosterone testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Global ALT testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Global cortisol testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Global creatinine testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Global AST testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Global other blood testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Regional Marketplace: Key Takeaways
Fig. 34 Regional Outlook, 2022 & 2030
Fig. 35 Regional Market Dashboard
Fig. 36 Regional Market Place: Key Takeaways
Fig. 37 North America, SWOT Analysis
Fig. 38 Europe, SWOT Analysis
Fig. 39 Asia Pacific, SWOT Analysis
Fig. 40 Latin America, SWOT Analysis
Fig. 41 MEA, SWOT Analysis
Fig. 42 North America
Fig. 43 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 44 U.S. Key Country Dynamics
Fig. 45 U.S. America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 46 Canada Key Country Dynamics
Fig. 47 Canada America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 48 Europe America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 49 UK Key Country Dynamics
Fig. 50 UK America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 51 Germany Key Country Dynamics
Fig. 52 Germany America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 53 France Key Country Dynamics
Fig. 54 France America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 55 Italy Key Country Dynamics
Fig. 56 Italy America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 57 Spain Key Country Dynamics
Fig. 58 Spain America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 59 Sweden Key Country Dynamics
Fig. 60 Sweden America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 61 Norway Key Country Dynamics
Fig. 62 Norway America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 63 Denmark Key Country Dynamics
Fig. 64 Denmark America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 65 Russia Key Country Dynamics
Fig. 66 Russia America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 67 Turkey Key Country Dynamics
Fig. 68 Turkey America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 69 Asia Pacific America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 70 Japan Key Country Dynamics
Fig. 71 Japan America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 72 China Key Country Dynamics
Fig. 73 China America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 74 India Key Country Dynamics
Fig. 75 India America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 76 Australia Key Country Dynamics
Fig. 77 Australia America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 78 Thailand Key Country Dynamics
Fig. 79 Thailand America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 80 South Korea Key Country Dynamics
Fig. 81 South Korea America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 82 Indonesia Key Country Dynamics
Fig. 83 Indonesia America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 84 Latin America America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 85 Brazil Key Country Dynamics
Fig. 86 Brazil America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 87 Mexico Key Country Dynamics
Fig. 88 Mexico America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 89 Argentina Key Country Dynamics
Fig. 90 Argentina America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 91 Middle East and Africa America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 92 South Africa Key Country Dynamics
Fig. 93 South Africa America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 94 Saudi Arabia Key Country Dynamics
Fig. 95 Saudi Arabia America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 96 UAE Key Country Dynamics
Fig. 97 UAE America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 98 Kuwait Key Country Dynamics
Fig. 99 Kuwait America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 100 Nigeria
Fig. 101 Nigeria America Blood Testing Market, 2018 - 2030 (USD Million)
Fig. 102 Strategy Mapping

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Quest Diagnostics
  • Biomerica, Inc
  • Becton, Dickinson and Company
  • Siemens Healthineers
  • Danaher Corporation
  • Trinity Biotech Plc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages129
PublishedAugust 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 91.61 Billion
Forecasted Market Value ( USD ) by 2030 $ 160.5 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Blood Testing Market by Product, Test Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Blood Testing Market by Product, Test Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Blood Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Image

Blood Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • 115 Pages
  • Global
From
Home Blood Testing Devices Market Report and Forecast 2024-2032 - Product Image

Home Blood Testing Devices Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Home Blood Testing Devices Market 2024-2028 - Product Image

Home Blood Testing Devices Market 2024-2028

  • Report
  • 206 Pages
  • Global
From
2024 Global Occult Blood Testing Market: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities - Product Image

2024 Global Occult Blood Testing Market: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities

  • Report
  • 243 Pages
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.